Danaher Corporation (0R2B.L)
USD 192.38
(5.22%)
USD 192.38
(5.22%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 13.49 Billion USD | -7.72% |
| 2022 | 14.62 Billion USD | -29.32% |
| 2021 | 20.68 Billion USD | 28.14% |
| 2020 | 16.14 Billion USD | 517.63% |
| 2019 | 2.61 Billion USD | -70.8% |
| 2018 | 8.95 Billion USD | -9.5% |
| 2017 | 9.89 Billion USD | -12.5% |
| 2016 | 11.3 Billion USD | -6.41% |
| 2015 | 12.07 Billion USD | 2482.21% |
| 2014 | 467.8 Million USD | 21.89% |
| 2013 | 383.8 Million USD | 122.86% |
| 2012 | -1.67 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 16.19 Billion USD | 2.28% |
| 2024 Q2 | 15.83 Billion USD | 29.46% |
| 2024 Q1 | 12.23 Billion USD | -10.53% |
| 2023 Q2 | 12.4 Billion USD | -8.51% |
| 2023 FY | 13.67 Billion USD | -6.49% |
| 2023 Q4 | 13.67 Billion USD | 25.63% |
| 2023 Q1 | 13.55 Billion USD | -8.08% |
| 2023 Q3 | 10.88 Billion USD | -12.23% |
| 2022 Q4 | 14.74 Billion USD | 4.59% |
| 2022 FY | 14.62 Billion USD | -29.32% |
| 2022 Q3 | 14.09 Billion USD | -12.32% |
| 2022 Q2 | 16.07 Billion USD | -10.98% |
| 2022 Q1 | 18.06 Billion USD | -12.69% |
| 2021 Q1 | 14.92 Billion USD | -6.45% |
| 2021 FY | 20.68 Billion USD | 28.14% |
| 2021 Q3 | 21.04 Billion USD | 60.64% |
| 2021 Q4 | 20.68 Billion USD | -1.71% |
| 2021 Q2 | 13.1 Billion USD | -12.22% |
| 2020 Q1 | 22.46 Billion USD | 814.65% |
| 2020 Q3 | 17.07 Billion USD | -3.77% |
| 2020 FY | 16.14 Billion USD | 517.63% |
| 2020 Q4 | 15.95 Billion USD | -6.55% |
| 2020 Q2 | 17.74 Billion USD | -21.02% |
| 2019 Q1 | 6.38 Billion USD | -28.68% |
| 2019 FY | 2.61 Billion USD | -70.8% |
| 2019 Q4 | 2.45 Billion USD | -41.99% |
| 2019 Q3 | 4.23 Billion USD | -25.11% |
| 2019 Q2 | 5.65 Billion USD | -11.45% |
| 2018 Q4 | 8.95 Billion USD | -9.03% |
| 2018 Q2 | 10.41 Billion USD | 10.07% |
| 2018 Q1 | 9.46 Billion USD | -4.33% |
| 2018 FY | 8.95 Billion USD | -9.5% |
| 2018 Q3 | 9.84 Billion USD | -5.52% |
| 2017 Q2 | 10.86 Billion USD | -2.52% |
| 2017 FY | 9.89 Billion USD | -12.5% |
| 2017 Q1 | 11.14 Billion USD | -1.41% |
| 2017 Q3 | 10.26 Billion USD | -5.57% |
| 2017 Q4 | 9.89 Billion USD | -3.59% |
| 2016 Q1 | 11.72 Billion USD | -2.92% |
| 2016 FY | 11.3 Billion USD | -6.41% |
| 2016 Q3 | 7.34 Billion USD | -30.45% |
| 2016 Q4 | 11.3 Billion USD | 54.01% |
| 2016 Q2 | 10.55 Billion USD | -10.0% |
| 2015 Q4 | 12.07 Billion USD | -8.34% |
| 2015 Q1 | 666.5 Million USD | 42.48% |
| 2015 Q3 | 13.17 Billion USD | 7454.07% |
| 2015 Q2 | -179.2 Million USD | -126.89% |
| 2015 FY | 12.07 Billion USD | 2482.21% |
| 2014 Q4 | 467.8 Million USD | 147.29% |
| 2014 Q3 | -989.2 Million USD | -292.38% |
| 2014 Q2 | -252.1 Million USD | -279.43% |
| 2014 Q1 | 140.49 Million USD | -63.39% |
| 2014 FY | 467.8 Million USD | 21.89% |
| 2013 FY | 383.8 Million USD | 122.86% |
| 2013 Q1 | 2.32 Billion USD | 238.24% |
| 2013 Q4 | 383.8 Million USD | -74.52% |
| 2013 Q2 | 1.82 Billion USD | -21.15% |
| 2013 Q3 | 1.5 Billion USD | -17.68% |
| 2012 Q4 | -1.67 Billion USD | 0.0% |
| 2012 FY | -1.67 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 17961.445% |
| Accuray Incorporated | 103.58 Million USD | -12924.926% |
| Align Technology, Inc. | -840.47 Million USD | 1705.292% |
| Elevance Health Inc. | 18.59 Billion USD | 27.439% |
| AxoGen, Inc. | 32.26 Million USD | -41714.914% |
| Boston Scientific Corporation | 8.23 Billion USD | -63.897% |
| CVS Health Corporation | 71.18 Billion USD | 81.048% |
| Cardinal Health, Inc. | 476 Million USD | -2734.454% |
| Centene Corporation | 506 Million USD | -2566.403% |
| DaVita Inc. | 10.65 Billion USD | -26.664% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 67.032% |
| Hologic, Inc. | 374.4 Million USD | -3503.632% |
| Humana Inc. | 5.51 Billion USD | -144.465% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -2631.462% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -149.049% |
| Masimo Corporation | 804 Million USD | -1578.109% |
| McKesson Corporation | 889 Million USD | -1417.66% |
| Patterson Companies, Inc. | 648.47 Million USD | -1980.564% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -188.106% |
| ResMed Inc. | 635.57 Million USD | -2022.806% |
| Henry Schein, Inc. | 2.57 Billion USD | -424.981% |
| Teladoc Health, Inc. | 468.6 Million USD | -2779.202% |
| Universal Health Services, Inc. | 5.24 Billion USD | -157.128% |
| Veeva Systems Inc. | -647.71 Million USD | 2183.025% |
| Baxter International Inc. | 11.16 Billion USD | -20.831% |
| Becton, Dickinson and Company | 14.46 Billion USD | 6.714% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 607.161% |
| Stryker Corporation | 10.02 Billion USD | -34.597% |
| Medtronic plc | 23.67 Billion USD | 43.021% |